Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in thedrug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
Two days after World Health Organisation (WHO) sought additional clarifications for emergency use listing of Bharat Biotech's vaccine Covaxin, Foreign Secretary Harsh Vardhan Shringla on Thursday said that the government is carefully following the d ...
Reacting to World Health Organisation (WHO) seeking additional clarifications for emergency use listing of Bharat Biotech's Covid-19 vaccine Covaxin, Professor of Centre for Community Medicine (CCM) in All India Institute of Medical Sciences (AIIMS) ...
World Health Organisation (WHO) official Dr Margaret Harris has said that the decision on Bharat Biotech's COVID-19 vaccine Covaxin's emergency use listing recommendation is expected within 24 hours. ...
Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the COVID-19 vaccine for children. ...
Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the COVID-19 vaccine for children. ...
As India on Thursday crossed 100 crore COVID-19 vaccination, Bharat Biotech's Chairman and Managing Director Dr Krishna Ella said that the firm is proud to have contributed to this 'historic landmark'. ...
Zydus Cadila's vaccine - ZyCoV-D is the first indigenously manufactured needle-free Covid-19 vaccine which is approved for children aged above 12 for emergency use in the country. Earlier, the Subject Experts Committee (SEC) has also recommended the ...
